NCT03859063 (LAST-long) is a NA clinical trial of Intervention in Stroke, sponsored by Norwegian University of Science and Technology.

Who is sponsoring NCT03859063?

NCT03859063 is sponsored by Norwegian University of Science and Technology.

What drugs are being tested in NCT03859063?

Interventions in NCT03859063: Intervention, Control.

Is NCT03859063 still recruiting?

NCT03859063 is currently completed. Last updated 16 September 2025.

Last reviewed 2025-09-16 · How we verify

NCT03859063: LAST-long

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Long-term Follow-up After Stroke (The LAST-long Trial)

Completed NA Last updated 16 September 2025

What this trial tests

NA trial testing Intervention in Stroke in 301 participants. Completed in 31 December 2024.

Timeline

11 April 2019

Primary endpoint
30 September 2024

31 December 2024

Quick facts

Lead sponsor	Norwegian University of Science and Technology
Phase	NA
Status	Completed
Study type	INTERVENTIONAL
Allocation	randomized
Design	parallel
Masking	double
Primary purpose	supportive care
Enrollment	301
Start date	11 April 2019
Primary completion	30 September 2024
Estimated completion	31 December 2024
Sites	4 locations across Norway

Drugs / interventions tested

Intervention
Control

Conditions studied

Stroke — all drugs for Stroke →

Sponsor

Norwegian University of Science and Technology

Who can join

18 and older, any sex, with Stroke. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

Despite the improved treatment of acute stroke over the past decades, those suffering from stroke still are at an increased risk of functional and cognitive decline in the long term. The most common consequences of stroke are functional impairments, cognitive impairments, depression and fatigue. These are also regarded as barriers to achieve optimal adherence to the guidelines regarding secondary prevention. The primary aim of this project is to evaluate the effectiveness of a multimodal individualized intervention to prevent functional decline in the long term after stroke.

Publications & conference data

8 peer-reviewed publications reference this trial (live from Europe PMC):

Late Breaking Abstracts.
· 2021 · cited 10× · PMID 35252583 · DOI 10.1177/23969873211044666
Multimodal individualised intervention to prevent functional decline after stroke: protocol of a randomised controlled trial on long-term follow-up after stroke (LAST-long).
Askim T, Hokstad A, Bergh E, Døhl Ø, et al · · 2023 · cited 4× · PMID 37164457 · DOI 10.1136/bmjopen-2022-069656
A multimodal individualized long-term intervention to prevent functional decline after stroke (LAST-long): a single blinded randomised controlled trial.
Askim T, Langlo SR, Bergh E, Døhl Ø, et al · · 2026 · cited 1× · PMID 41323876 · DOI 10.1016/j.lanepe.2025.101531
11th European Stroke Organisation Conference Abstracts - 21-23 May 2025, Helsinki, Finland: Late Breaking Abstracts.
· 2025 · cited 1× · PMID 40726473 · DOI 10.1177/23969873251345751
Reduced physical activity level was associated with poorer quality of life during the early phase of the COVID-19 pandemic: a sub-study of the last-long trial.
Hokstad A, Thommessen B, Ihle-Hansen H, Indredavik B, et al · · 2023 · cited 1× · PMID 38058014 · DOI 10.2340/jrm.v55.12352
ESOC 2023 Abstract Book
· 2023
ESOC 2022 Abstract Book
· 2022
ESOC 2022 – Late Breaking Science, Ongoing Trials & Young Stroke Physicians and Researchers
· 2022

Verify or expand the search:

Other trials of Intervention

Trials testing the same drug.

NCT07038317 — A Text Messaging Trial to Test Vaping Health Messages Optimized to Young Adults' Vaping Status · NA · not yet recruiting
NCT06112431 — Eye Health Intervention Study in Upper Manhattan · NA · not yet recruiting
NCT07202390 — Intraarticular Gold Microparticles for Knee Osteoarthritis · NA · not yet recruiting
NCT07444736 — Effect of 8 Weeks of Resistance Training With Blood Flow Restriction on Muscle Strength, Clinical Parameters, Biochemica · NA · enrolling by invitation
NCT07376668 — Effects of a WhatsApp-assisted Prehabilitation for Patient Undergoing Elective Colorectal Cancer Surgery · NA · not yet recruiting

Other recruiting trials for Stroke

Currently open trials in the same condition.

NCT06615973 — Screening for Social Determinants of Health (SDOH) and Cognitive Function in Individuals With History of Stroke · recruiting
NCT07494890 — Measurement Properties of Mechanical Cost of Walking for Individuals With Walking Impairment · NA · recruiting
NCT07356011 — Exoskeleton for Balance · NA · recruiting
NCT07523503 — Unilateral Versus Bilateral Task-specific Training on Motor Impairment, Upper Extremity Function, and Hand Dexterity in · NA · recruiting
NCT06704074 — Virtual Reality Task Oriented Training on Upper Limb Function in Stroke Patients · NA · recruiting

Other Norwegian University of Science and Technology trials

Trials by the same sponsor.

NCT07521891 — Socket-leg Interface Movements in Transtibial Amputees · NA · not yet recruiting
NCT07463001 — Optimization and Testing Effectiveness of a Collaborative Intervention for School Attendance Problems in Norwegian Munic · NA · not yet recruiting
NCT07422597 — Prostate Risk Or Radiology Assessment Non-inferiority Design, Upfront MRI or Risk Calculator in Men With Suspected Prost · NA · recruiting
NCT06558851 — The Effect of Systematic Endurance Training in Treatment of Women With Lipedema · NA · active not recruiting
NCT06893874 — A Pragmatic Trial of Machine Prescription for Migraine · recruiting

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT03859063 (US National Library of Medicine, public domain)
Publications: Europe PMC API search by NCT ID, retrieved 10 June 2026
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by Norwegian University of Science and Technology
Last refreshed: 16 September 2025

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT03859063.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing